BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Business

  Century Therapeutics Announces Leadership Changes

  Century Therapeutics today announced the appointment of Greg Russotti, Ph.D., as ad-interim Chief Executive Officer, effective April 11, 2023.

  April 12, 2023

   · 

  8 min read
• Business

  Sherlock Biosciences Appoints Maurice Exner as Chief Scientific Officer

  Sherlock Biosciences today announced that veteran research and development executive Maurice Exner has been appointed as the company’s first Chief Scientific Officer.

  April 12, 2023

   · 

  3 min read
• Genetown

  Ablative Solutions, Inc. Announces Enrollment Completion of TARGET BP I Study for Patients with Uncontrolled Hypertension

  Ablative Solutions, Inc., a company pioneering new approaches to the treatment of hypertension, today announced the completion of patient enrollment in the TARGET BP I Pivotal Study evaluating alcohol-mediated renal denervation with the Peregrine System.

  April 12, 2023

   · 

  2 min read
• Biotech Bay

  Veracyte Announces Seven Abstracts for Its Decipher Urologic Cancer Tests To Be Presented at 2023 AUA Annual Meeting

  Veracyte, Inc . (Nasdaq: VCYT) announced today that seven abstracts highlighting new data from studies of the company’s Decipher urologic cancer tests will be presented at the American Urological Association (AUA) Annual Meeting, taking place April 28-May 1, 2023.

  April 12, 2023

   · 

  5 min read
• Bio NC

  Tenax Therapeutics Provides 2023 Business Update

  Tenax Therapeutics, Inc. (Nasdaq: TENX) today provided a business update outlining the Company’s product development plans for 2023.

  April 12, 2023

   · 

  8 min read
• Genetown

  Anika to Participate in the 22nd Annual Needham Virtual Healthcare Conference

  Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that management will participate in the 22nd Annual Needham Virtual Healthcare Conference on Thursday, April 20, 2023.

  April 12, 2023

   · 

  1 min read
• Drug Development

  Sirnaomics Launches Phase I Clinical Trial for GalNAc Factor XI Program

  Sirnaomics Ltd., a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announced the launch of a Phase I clinical trial of STP122G based on the Group’s GalNAc Factor XI Program.

  April 12, 2023

   · 

  4 min read
• BioCapital

  Neuronascent Announces the Expansion of its Board of Directors

  Neuronascent Inc., a clinical-stage, neuron generating, biopharmaceutical company, is pleased to announce the addition of industry leader Emer Leahy, Ph.D., MBA, to its Board of Directors.

  April 12, 2023

   · 

  3 min read
• Genetown

  CENTOGENE Launches NEW CentoGenome®, World’s Most Comprehensive Whole Genome Sequencing Solution for Diagnosis of Rare and Neurodegenerative Diseases

  Centogene N.V., the essential life science partner for data-driven answers in rare and neurodegenerative diseases, announced the launch of NEW CentoGenome®, an enhanced Next Generation Sequencing -based assay.

  April 12, 2023

   · 

  6 min read
• Biotech Beach

  Function Oncology Launches to Transform the Future of Targeted Cancer Treatment with CRISPR-powered Personalized Functional Genomics Platform

  Function Oncology, a precision medicine company advancing a CRISPR-powered personalized functional genomics platform to transform the future of targeted cancer treatment, announced its launch with $28 Million in Series A financing.

  April 12, 2023

   · 

  5 min read